Literature DB >> 30129928

TGF-β induced epithelial-mesenchymal transition in an advanced cervical tumor model by 3D printing.

Y Pang1, S S Mao, R Yao, J Y He, Z Z Zhou, L Feng, K T Zhang, S J Cheng, W Sun.   

Abstract

An advanced in vitro cervical tumor model was established by 3D printing to study the epithelial-to-mesenchymal transition (EMT), which is a very important stage of dissemination of carcinoma leading to metastatic tumors. A HeLa/hydrogel grid construct composed of gelatin, alginate, Matrigel and HeLa cells was fabricated by forced extrusion in a layer-by-layer fashion. HeLa cells rapidly proliferated, formed spheroids and presented tumorigenic characteristic in the 3D-printed structure. With the supplement of TGF-β, aggregated HeLa cells started to disintegrate, and some of them changed into fibroblast-like spindle morphology, which indicated that EMT was induced. The down-regulation of epithelial marker E-cadherin, and up-regulation of mesenchymal markers such as snail, vimentin and N-cadherin were all observed in the 3D-printed model, and performed differently in 3D and 2D models. The TGF-β induced EMT was inhibited by the treatment of disulfiram and EMT pathway inhibitor C19 in a dose dependent manner, showing great potential for future studies of a therapeutic program towards cervical tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30129928     DOI: 10.1088/1758-5090/aadbde

Source DB:  PubMed          Journal:  Biofabrication        ISSN: 1758-5082            Impact factor:   9.954


  12 in total

Review 1.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

Review 2.  C-C Chemokine Receptor 7 in Cancer.

Authors:  Colin A Bill; Christopher M Allen; Charlotte M Vines
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

Review 3.  In Vitro Human Cancer Models for Biomedical Applications.

Authors:  Jane Ru Choi; Gül Kozalak; Ighli di Bari; Quratulain Babar; Zahra Niknam; Yousef Rasmi; Kar Wey Yong
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

4.  Recent Advances on Utilization of Bioprinting for Tumor Modeling.

Authors:  Y Cagri Oztan; Nashat Nawafleh; Yiqun Zhou; Piumi Y Liyanage; Sajini D Hettiarachchi; Elif S Seven; Roger M Leblanc; Allal Ouhtit; Emrah Celik
Journal:  Bioprinting       Date:  2020-01-29

5.  3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments.

Authors:  Fanben Meng; Carolyn M Meyer; Daeha Joung; Daniel A Vallera; Michael C McAlpine; Angela Panoskaltsis-Mortari
Journal:  Adv Mater       Date:  2019-01-21       Impact factor: 30.849

Review 6.  Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research.

Authors:  Fahriye Duzagac; Gloria Saorin; Lorenzo Memeo; Vincenzo Canzonieri; Flavio Rizzolio
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

Review 7.  RNA Sequencing and Cell Models of Virus-Associated Cancer (Review).

Authors:  O V Kurmyshkina; A A Bogdanova; P I Kovchur; A I Fetyukov; T O Volkova
Journal:  Sovrem Tekhnologii Med       Date:  2022-01-28

8.  Establishing a 3D In Vitro Hepatic Model Mimicking Physiologically Relevant to In Vivo State.

Authors:  Hyun Kyoung Kang; Madina Sarsenova; Da-Hyun Kim; Min Soo Kim; Jin Young Lee; Eun-Ah Sung; Myung Geun Kook; Nam Gyo Kim; Soon Won Choi; Vyacheslav Ogay; Kyung-Sun Kang
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

9.  Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks.

Authors:  Sonja K Schmidt; Rafael Schmid; Andreas Arkudas; Annika Kengelbach-Weigand; Anja K Bosserhoff
Journal:  Cells       Date:  2019-10-22       Impact factor: 6.600

Review 10.  Emerging organoid models: leaping forward in cancer research.

Authors:  Han Fan; Utkan Demirci; Pu Chen
Journal:  J Hematol Oncol       Date:  2019-12-29       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.